These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 4744591)

  • 1. Value of laboratory indicators in Hodgkin's disease: preliminary results.
    Ray GR; Wolf PH; Kaplan HS
    Natl Cancer Inst Monogr; 1973 May; 36():315-23. PubMed ID: 4744591
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum ferritin and other biological parameters as indicators of tumor activity in Hodgkin's disease].
    Hermosa V; Mazo E; Baró J; Castillo E; Cordovilla JJ; Carril J; Zubizarreta A
    Sangre (Barc); 1985; 30(2):154-8. PubMed ID: 2409612
    [No Abstract]   [Full Text] [Related]  

  • 3. Ceruloplasmin in Hodgkin's disease.
    Koprivová H; Dienstbier Z; Sámal M; Foltýnová V
    Neoplasma; 1982; 29(3):333-40. PubMed ID: 7133228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma iron and copper in Hodgkin's disease. A comparison with other laboratory indicators.
    Gobbi PG; Scarpellini M; Minoia C; Pozzoli L; Perugini S
    Haematologica; 1979 Aug; 64(4):416-32. PubMed ID: 121577
    [No Abstract]   [Full Text] [Related]  

  • 5. [Significance of some humoral and cytological indices in active stages of Hodgkin's disease].
    Barbui T; Dini E; Chisesi T; Corà R; Franchi F; Cazzavillan M; Battista R
    Haematologica; 1972; 57(9):488-92. PubMed ID: 4125445
    [No Abstract]   [Full Text] [Related]  

  • 6. [Blood protein, iron and copper, and leukocyte alkaline phosphatase in lymphoma].
    Martinetto P; Neretto G; Agricola R; Pellerito R; Giovanelli E; Fassio D
    Arch Sci Med (Torino); 1980; 137(1):119-26. PubMed ID: 7458644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formal discussion of F. Teillet et al's paper, "a reappraisal of clinical and biological signs in staging of Hodgkin's disease.
    Kaplan HS
    Cancer Res; 1971 Nov; 31(11):1730. PubMed ID: 5121675
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of copper oxidase (ceruloplasmin) and related tests in Hodgkin's disease.
    Wolf PL; Ray G; Kaplan H
    Clin Biochem; 1979 Dec; 12(6):202-4. PubMed ID: 535145
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum ceruloplasmin levels in Hodgkin's disease and malignant lymphomas in correlation with serum copper levels.
    Sirsat AV; Raste AS; Talavdekar RV; Advani SH
    Indian J Cancer; 1979 Jun; 16(2):32-4. PubMed ID: 546729
    [No Abstract]   [Full Text] [Related]  

  • 10. Granulocyte alkaline phosphatase activity in Hodgkin's disease.
    Bobory J
    Acta Med Acad Sci Hung; 1971; 28(1):1-5. PubMed ID: 5133497
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diagnostic value of determination of ceruloplasmin activity and haptoglobin level in patients with lymphogranulomatosis].
    Vasygova NF; Lorie IuI
    Vestn Akad Med Nauk SSSR; 1974; (12):20-4. PubMed ID: 4446705
    [No Abstract]   [Full Text] [Related]  

  • 12. The serum iron level, hematocrit, sedimentation rate, and leukocyte alkaline phosphatase level in pediatric patients with Hodgkin's disease.
    Jaffe N; Bishop JM
    Cancer; 1970 Aug; 26(2):332-7. PubMed ID: 5456754
    [No Abstract]   [Full Text] [Related]  

  • 13. [Blood copper and ceruloplasmin levels in hemolymphopathies. I. Malignant lymphoma].
    Tura S; Bernardi L; Baccarani M; Sanguinetti F; Branzi A
    G Clin Med; 1968 Nov; 49(11):1090-104. PubMed ID: 5757473
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum copper, serum ceruloplasmin, and erythrocyte sedimentation rate measurements in children with Hodgkin's disease, non-Hodgkin's lymphoma, and nonmalignant lymphadenopathy.
    Margerison AC; Mann JR
    Cancer; 1985 Apr; 55(7):1501-6. PubMed ID: 3978543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of leukocyte alkaline phosphatase in Hodgkin's disease.
    Bennett JM; Nathanson L; Rutenburg AM
    Arch Intern Med; 1968 Apr; 121(4):338-41. PubMed ID: 5645706
    [No Abstract]   [Full Text] [Related]  

  • 16. [Serum complement level in Hodgkin's disease].
    Hamladji RM; Belhani M; Irunberry J; Benabadji M; Colonna P
    Nouv Rev Fr Hematol; 1972; 12(5):673-81. PubMed ID: 4120941
    [No Abstract]   [Full Text] [Related]  

  • 17. Haematological and clinical parameters in assessing activity in Hodgkin's disease and other malignant lymphomas.
    Simmons AV; Spiers AS; Fayers PM
    Q J Med; 1973 Jan; 42(165):111-24. PubMed ID: 4569732
    [No Abstract]   [Full Text] [Related]  

  • 18. [Some laboratory indicators of lymphogranulomatosis].
    Vasygova NF
    Sov Med; 1973 Aug; 36(8):57-62. PubMed ID: 4130223
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blood iron and blood copper in acute and chronic leukemia and in Hodgkin's disease].
    RECHENBERGER J
    Dtsch Z Verdau Stoffwechselkr; 1957 Apr; 17(2):78-85. PubMed ID: 13437842
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hodgkin's disease. Lymphoadenography, cupremia and sideremia].
    Weissleder H; Marongiu F
    Prensa Med Argent; 1966 May; 53(18):1001-7. PubMed ID: 5916206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.